Media Coverage

Fact Sheet: Update on the Biden-⁠Harris Administration’s Commitment to Addressing the Global Mpox Outbreak

At the UN General Assembly in September, President Biden announced that the United States is prepared to commit at least $500 million and to donate up to one million doses of mpox vaccines to support African countries in preventing and responding to this outbreak. We are delivering on that commitment, with two-thirds of our global mpox funding pledge fulfilled, and all of our pledged vaccine doses available now for countries that are ready to receive the doses.

Read More »

US, global health organizations to help ensure access to HIV prevention drug

America’s top global health program and other global health groups said today that they’ll work together to ensure access for two million people to a drug shown to prevent HIV infection.

The drug, lenacapavir from the drugmaker Gilead, was initially developed as a treatment for patients with drug-resistant HIV. But in clinical trials this year lenacapavir showed almost 100 percent protection against acquiring the virus.

Read More »

Biden-Harris Administration Policy Expands Access to Life-Saving Organs for People with HIV

The U.S. Department of Health and Human Services (HHS) announced a final rule that will expand access to kidney and liver transplants for people with HIV by removing clinical research requirements for these transplants. This action marks a significant step forward in increasing the availability of life-saving organs for all patients regardless of their HIV status while continuing to reduce barriers and stigma for people with HIV.

Read More »

Hate delays getting your prescriptions approved?

Putting limits on the price of expensive drugs may sound like a great way for a state to save its residents money and encourage them to fill their prescriptions and stay healthy. That is what the new wave of prescription drug affordability boards, or PDABs, in 11 states are promising.

Read More »